annual

Vantage Markets Wins Three Prestigious Awards at the Gazet International Magazine Annual Awards 2025

PORT VILA, Vanuatu, March 18, 2025 /PRNewswire/ -- Vantage Markets is proud to announce its latest industry recognition at the Gazet…

2 weeks ago

Relativity Announces its Fourth Annual AI Visionaries List

The list features leaders who have played pivotal roles in AI adoption CHICAGO, March 17, 2025 /PRNewswire/ -- Relativity, a…

3 weeks ago

World Trade Centers Association’s 55th Annual Global Business Forum to Convene in Marseille, France

Global business leaders, policymakers and industry experts to gather for timely discussions on trade, investment and partnership opportunities in one…

3 weeks ago

Zentalis Pharmaceuticals Presents Updated Clinical Data at the Society of Gynecologic Oncology 2025 Annual Meeting on Womens Cancer

March 15, 2025 11:25 ET  | Source: ZENTALIS PHARMACEUTICALS Azenosertib median duration of response (mDOR) updated to 6.3 months in…

3 weeks ago

Notice to Convene Annual General Meeting 2025 – Item 6: Election of members to the Board of Directors

Company announcement no. 4– 25 14 March 2025 Notice to Convene Annual General Meeting 2025 - Item 6: Election of…

3 weeks ago

Nokia has published its Nokia in 2024 Annual Report and filed its Annual Report on Form 20-F for 2024

Nokia CorporationStock Exchange Release13 March 2025 at 23:30 EETNokia has published its Nokia in 2024 Annual Report and filed its Annual…

3 weeks ago

Integra LifeSciences to Present at the Oppenheimer 35th Annual Healthcare MedTech & Services Conference

PRINCETON, N.J., March 13, 2025 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (NASDAQ: IART), a leading global medical technology company, announced…

3 weeks ago

The Adecco Group: 2024 ANNUAL REPORT

ZURICH, March 12, 2025 /PRNewswire/ -- The Adecco Group 2024 Annual Report is now available in the Ad Hoc section of the…

3 weeks ago

Axtria Ignite 2025: Annual Conference to Focus on Shaping Leadership in an Agentic Era for Life Sciences

Next-Gen Therapies and Data-Driven Innovation Take Center Stage as Industry Leaders Explore AI-Led Patient-Centric Strategies to Revolutionize Drug Commercialization BERKELEY…

3 weeks ago

Late-Breaking ESK-001 Phase 2 OLE Data Presented at 2025 AAD Annual Meeting Demonstrate Robust Clinical Responses Over 52-Weeks in Psoriasis

ESK-001 is a highly selective, next-generation oral tyrosine kinase 2 (TYK2) inhibitor currently under development in moderate-to-severe plaque psoriasis and…

4 weeks ago